Citation Impact
Citing Papers
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
2007 Standout
Activation of β-catenin by carcinogenic Helicobacter pylori
2005
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Obesity alters gut microbial ecology
2005 Standout
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
Increased intestinal permeability as a predictor of bacterial infections in patients with decompensated liver cirrhosis and hemorrhage
2010
Assessment of the prognosis of cirrhosis: Child–Pugh versus MELD
2004
Glutamine and the preservation of gut integrity
1993 Standout
Dysregulation of growth factor signaling in human hepatocellular carcinoma
2006
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Tumors are unique organs defined by abnormal signaling and context
2001
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Bowel Disorders
2016 Standout
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
Intestinal Permeability in Cirrhotic Patients With and Without Spontaneous Bacterial Peritonitis: Is the Ring Closed?
2009
Intestinal permeability and complications in liver cirrhosis: A prospective cohort study
2012
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium
2007 StandoutNobel
The β-Thalassemias
1999 Standout
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis
2008 StandoutNobel
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Hepatocellular carcinoma
2012 Standout
Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease
2004
Porphyrias
2010 Standout
Heat Stroke
2002 Standout
Intestinal Permeability in Long-Term Follow-up of Patients with Celiac Disease on a Gluten-Free Diet
2005
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda
1997
Meta–Analysis of Interferon Randomized Trials in the Treatment of Viral Hepatitis C: Effects of Dose and Duration
1996
Pathways to the impairment of human nutritional status by gastrointestinal pathogens
1993
Increased Gut Permeability Following Burn Trauma
1991
Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes
2012
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
2019 Standout
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
MELD and PELD: Application of survival models to liver allocation
2001
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Lactulose-L-rhamnose intestinal permeability test in patients with liver cirrhosis
2001
Intestinal mucosal barrier function in health and disease
2009 Standout
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
1995 Standout
Xanthine oxidase activity in the circulation of rats following hemorrhagic shock
1993
Cachexia in liver cirrhosis
2002
The Frequency of Hemochromatosis–Associated Alleles Is Increased in British Patients With Sporadic Porphyria Cutanea Tarda
1997
Intestinal permeability in cirrhotic patients with and without ascites
2005
Serum insulin‐like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus‐related cirrhosis
2002
Gut flora in health and disease
2003 Standout
Assessment of Intestinal Permeability and Absorption in Cirrhotic Patients with Ascites Using Combined Sugar Probes
2004
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Metastasis to bone: causes, consequences and therapeutic opportunities
2002 Standout
Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis
2010
Inhibition of hepatitis C virus p7 membrane channels in a liposome-based assay system
2007
Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage
2009
Intestinal permeability: An overview
1995
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
2000
Gastrointestinal dysfunction in liver cirrhosis
2014
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
NF-κB functions as a tumour promoter in inflammation-associated cancer
2004 StandoutNature
Natural history of liver fibrosis progression in patients with chronic hepatitis C
1997 Standout
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
2016
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Genomics and Signaling Pathways in Hepatocellular Carcinoma
2007
Dietary Habits and Their Relations to Insulin Resistance and Postprandial Lipemia in Nonalcoholic Steatohepatitis
2003
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Increased intestinal macromolecular permeability and urine nitrite excretion associated with liver cirrhosis with ascites
2008
Helicobacter pylori and gastrointestinal tract adenocarcinomas
2002
Aberrant Expression of Fetal RNA-Binding Protein p62 in Liver Cancer and Liver Cirrhosis
2001
Baterial Translocation in Humans
2001
The human microbiome: at the interface of health and disease
2012 Standout
Cytochrome P4502C9 genotype in Southeast Anatolia and possible relation with some serum tumour markers and cytokines.
2001
Control Mechanisms of Adenine Nucleotide Metabolism of Ascites Tumor Cells
1971
Dialogue between E. coli free radical pathways and the mitochondria of C. elegans
2015 StandoutNobel
The Liver in Thalassaemia Major: Ultra‐Structural Observations
1977
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
Origin of the delayed feedback control of glucose utilization in ascites tumor cells
1972 StandoutNobel
Electrochemiluminescence (ECL)
2004 Standout
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
2009
Amino Acid Variations in Hepatitis C Virus P7 and Sensitivity to Antiviral Combination Therapy with Amantadine in Chronic Hepatitis C
2006
Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature
2013
Increased prevalence of intestinal inflammation in patients with liver cirrhosis
1999
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Effect of running intensity on intestinal permeability
1997
Small intestinal bacterial overgrowth: a comprehensive review.
2007
Works of G Budillon being referenced
Jejunal bacterial overgrowth and intestinal permeability in children with immunodeficiency syndromes.
1990
Investigation of intestine function during acute viral hepatitis using combined sugar oral loads.
1987
Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation
1996
Activation of Fetal Promoters of Insulinlike Growth Factors Ii Gene in Hepatitis C Virus-Related Chronic Hepatitis, Cirrhosis, and Hepatocellular Carcinoma
1996
Interferon‐α plus amantadine in chronic hepatitis C resistant to interferon alone: a pilot randomized study
2001
Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects
2001
Effect of Helicobacter pyloriinfection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis
1999
Evaluation of Heparin Toxicity in the Isolated and PerfusedRat Liver
1986
In Vivo and In Vitro Studies of Cytosolic Phospholipase A2Expression inHelicobacter pyloriInfection
2001
Control of the citric acid cycle by glyoxylate. 2. Mechanism of the inhibition of respiration in liver and kidney particles
1962
Hyperuricemia induced by fructose load in liver cirrhosis.
1992
The Cholecystokinin Effect on Human Intestinal Permeability: Influence of Chenodeoxycholic and Ursodeoxycholic Acid Administration
1982
Malabsorption and nutritional abnormalities in patients with liver cirrhosis.
1990
Quantitative Analysis of Aldolase A mRNA in Liver Discriminates between Hepatocellular Carcinoma and Cirrhosis
2000
Cryptic epitopes on alpha-fetoprotein induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis patients.
1999
Proceedings: Lysosomal changes in human and experimental iron overload.
1974
A Novel Association between HLA and Disease: Porphyria cutanea tarda and HLA-AW32
1980
Intestinal permeability after single dose gluten challenge in coeliac disease.
1991
Investigation of intestine and liver function in cirrhosis using combined sugar oral loads
1985
Treatment of chronic hepatitis C with recombinant interferon alfa.
1992
Changes in intestinal permeability to lactulose induced by cytotoxic chemotherapy.
1982